-
公开(公告)号：US12022786B2
公开(公告)日：2024-07-02
申请号：US17431036
申请日：2020-02-14
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Natarajan Sankaran , Sivakumar Arumugam , Muthuraman Gnanamani , Kulithalai Viswanathan Krishnamurthy , Ugraiah Amilineni
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Natarajan Sankaran , Sivakumar Arumugam , Muthuraman Gnanamani , Kulithalai Viswanathan Krishnamurthy , Ugraiah Amilineni
Abstract: The present invention discloses a method of isolating secondary metabolites, specifically arjunolic acid, from the calli and/or the suspension cultures derived from the pluripotent cambium tissue of Terminalia arjuna. The invention also discloses a method of inducing callus, establishing and maintaining suspension cultures of callus derived from the cambium of Terminalia arjuna for the isolation of secondary metabolites.
-
公开(公告)号：US11744807B2
公开(公告)日：2023-09-05
申请号：US17151172
申请日：2021-01-17
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Sarang Bani , Anjali Pandey
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Sarang Bani , Anjali Pandey
IPC: A61K31/122 , A61P11/00 , A61K31/09 , A61K47/10 , A61K36/9066
CPC classification number: A61K31/122 , A61K31/09 , A61K36/9066 , A61K47/10 , A61P11/00
Abstract: The present invention discloses a method for therapeutic management of pulmonary fibrosis in mammals using a composition comprising iso-garcinol or octahydrocurcumin or a combination of iso-garcinol and octahydrocurcumin. The composition is very suitable for treating pulmonary fibrosis due to viral infections, specifically COVID 19 and for improving lung function during prognosis.
-
公开(公告)号：US20230201134A1
公开(公告)日：2023-06-29
申请号：US17564490
申请日：2021-12-29
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Sarang Bani , Anjali Pandey
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Sarang Bani , Anjali Pandey
IPC: A61K31/12 , A61K31/585 , A61P25/00
CPC classification number: A61K31/12 , A61K31/585 , A61P25/00
Abstract: The invention discloses a composition and method for therapeutically managing a demyelinated disorder through remyelination. The invention includes a composition comprising Withaferin A and Bisdemethoxycurcumin (BDMC), and a pharmaceutically or nutraceutically acceptable excipients, which can be effectively formulated as tablets and capsules. The invention also covers use of composition for effectively managing a demyelinated disorder through remyelination.
-
公开(公告)号：US20220388939A1
公开(公告)日：2022-12-08
申请号：US17825689
申请日：2022-05-26
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Nagarajan Muthukaman , Pentakota Paradesi Naidu
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Nagarajan Muthukaman , Pentakota Paradesi Naidu
IPC: C07C67/08 , C07C69/736 , C07C67/293
Abstract: The invention discloses novel intermediates in the synthesis of Calebin A represented by formula 3. The invention also covers processes for the synthesis of Calebin-A and its analogs using compounds of formula 3.
-
公开(公告)号：US11419906B2
公开(公告)日：2022-08-23
申请号：US16836066
申请日：2020-03-31
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Kirankumar Beede , Sivakumar Arumugam , Shaheen Majeed
IPC: A61K35/742 , A61K38/46 , A61K38/47
Abstract: The present invention discloses the potential of probiotic bacteria Bacillus coagulans individually or in combination with multi-enzyme complex for reducing gluten content in foods rich in gluten and for the increased utilization of gluten. The invention further discloses a method for the management of gluten intolerance using composition comprising Bacillus coagulans and multi-enzyme complex in mammals.
-
Patent Agency Ranking
公开(公告)号：US11351102B2
公开(公告)日：2022-06-07
申请号：US17003760
申请日：2020-08-26
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur
Abstract: The present invention discloses a method for protecting mammalian skin against the harmful effects of UV radiation and environmental pollutants, using one or plant actives selected from group comprising a composition comprising not less than 10% w/w oroxylin A, not less than 10% w/w baicalein and not less than 2% w/w chrysin; 95% w/w oxyresveratrol; 95% w/w tetrahydrocurcumin; 90% w/w pterostilbene and a composition comprising at least 10% w/w β-glucogallin and at least 10% w/w total mucic acid gallates. The invention also discloses a method for cleansing and rejuvenating mammalian skin, exposed to environmental pollutants and UV radiation using the aforesaid plant actives.
-
公开(公告)号：US11202810B2
公开(公告)日：2021-12-21
申请号：US16372635
申请日：2019-04-02
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Furqan Ali , Sivakumar Arumugam , Shaheen Majeed
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Furqan Ali , Sivakumar Arumugam , Shaheen Majeed
IPC: A61K35/742 , A61P1/00 , A61K38/43 , A61K9/48 , A61K9/00
Abstract: The present invention discloses a stable probiotic composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex for the utilization of lactose and therapeutic management of lactose intolerance. It also discloses a method for the management of lactose intolerance using composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex.
-
公开(公告)号：US20210220424A1
公开(公告)日：2021-07-22
申请号：US17151124
申请日：2021-01-16
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur , Mohammad Mansoor Ansari
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur , Mohammad Mansoor Ansari
IPC: A61K36/8905 , A61K36/185 , A61K31/05 , A61K31/343 , A61P3/04
Abstract: The invention discloses a composition comprising Cyperus rotundus extract and Passiflora edulis extract comprising piceatannol, scirpusin B, scirpusin A, cyperusphenol A and cyperusphenol B, standardized to contain 6-10% w/w total stilbenes. The invention also discloses the use of the above mentioned composition in enhancing energy expenditure in mammalian adipose cellular systems by the conversion of white adipose tissues to brown adipose tissues, inhibition of adipogenesis and for preventing weight gain in mammals.
-
公开(公告)号：US10959980B2
公开(公告)日：2021-03-30
申请号：US16441465
申请日：2019-06-14
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam
IPC: A61K31/353 , A61P3/10 , A61K9/00
Abstract: The present invention discloses a composition comprising not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use in the therapeutic management of hypertriglyceridemia, associated with chemotherapy and hyperglycemia.
-
公开(公告)号：US20210059919A1
公开(公告)日：2021-03-04
申请号：US17003760
申请日：2020-08-26
Applicant: Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur
Inventor： Muhammed Majeed , Kalyanam Nagabhushanam , Lakshmi Mundkur
Abstract: The present invention discloses a method for protecting mammalian skin against the harmful effects of UV radiation and environmental pollutants, using one or plant actives selected from group comprising a composition comprising not less than 10% w/w oroxylin A, not less than 10% w/w baicalein and not less than 2% w/w chrysin; 95% w/w oxyresveratrol; 95% w/w tetrahydrocurcumin; 90% w/w pterostilbene and a composition comprising at least 10% w/w β-glucogallin and at least 10% w/w total mucic acid gallates. The invention also discloses a method for cleansing and rejuvenating mammalian skin, exposed to environmental pollutants and UV radiation using the aforesaid plant actives.
-
-
-
-
-
-
-
-
-
Search Results
257
records
(took 0.018 seconds)
